New prize honors MedTech innovator(s)
It is the inaugural “Thomas J. Fogarty Prize,"
Nominations have opened for the inaugural “Thomas J. Fogarty Prize,” a prestigious new recognition for an innovator or team who has developed and brought to market a life-changing medical technology. The award consists of an unrestricted $100,000 cash prize, a custom-cast bronze medal, and a formal celebratory dinner and award ceremony with MedTech leaders in Silicon Valley.
Named in honor of cardiovascular surgeon and serial medical technology innovator Thomas J. Fogarty, MD, the Fogarty Prize is made possible through a foundational grant from the Linda and Mike Mussallem Foundation, with Silicon Valley-based law firm, Wilson Sonsini, also contributing to the prize endowment.
Fogarty dedicated his career to improving medicine. His balloon embolectomy catheter, invented when he was still in medical school, revolutionized vascular surgery and launched an era of minimally invasive device innovation that has improved and saved the lives of millions of people. He also invented a legion of other surgical tools and technologies and has been recognized by numerous organizations for his contributions to medical science, including the National Inventors Hall of Fame and the Presidential Medal of Technology and Innovation.
Over his career, Fogarty, age 91, acquired 190 medical patents for his revolutionary work and was the Founder or Co-Founder of more than 45 medical technology companies.
The Fogarty Prize recognizes a singular, clinically impactful technology, which differentiates it from a lifetime achievement award. Recipients must be individuals (up to three per award); companies are not eligible. The nomination period closes on July 31, and the winner(s) will be announced in August. The award will be presented at a formal dinner in October 2025 in Silicon Valley, California, the night before the annual Thomas J. Fogarty, MD: Focus on Innovation Lecture.
To apply, click here.
Like what you've read?
Forward to a friend!